Market Tracker

07/31 6:05pm ET

Depomed Inc (NASDAQ:DEPO)

9.95
Data as of Jul 31
 -1.00 / -9.13%
Today’s Change
6.25
Today|||52-Week Range
15.39
-5.95%
Year-to-Date
No recent news for Depomed Inc.

Today’s Trading

Previous close10.95
Today’s open10.82
Day’s range9.93 - 10.92
Volume1,337,775
Average volume (3 months)985,599
Market cap$635.0M
Dividend yield--
Data as of 3:59pm ET, 07/31/2014

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-66.67%
Earnings growth (next 5 years)+72.00%
Revenue growth (last year)+47.78%
P/E ratio8.7
Price/Sales4.47
Price/Book4.57

Competitors

 Today’s
change
Today’s
% change
NEPTNeptune Technologies...-0.04-1.83%
CMPERelmada Therapeutics...-0.02-0.66%
TEVATeva Pharmaceutical ...-1.38-2.51%
Data as of 4:03pm ET, 07/31/2014

Financials

Next reporting dateAugust 7, 2014
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$134.2M
Annual profit (last year)$43.3M
Net profit margin32.27%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
James A. Schoeneck
CFO, Senior VP &
Head-Investor Relations
August J. Moretti
Corporate headquarters
Newark, California

Forecasts